-
A once-daily controlled-release formulation of hydromorphone has been approved by the FDA.
-
Haiti is one of the poorer countries in the world, with the highest per-capita rate of tuberculosis (TB) in Latin America and the Caribbean.
-
FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions.
-
-
The role of statins in treatment of dyslipidemia is well established. There are, however, limitations of statins: Residual risk is substantial, not all persons can tolerate statins, and, even with full-dose statin treatment, some patients do not achieve lipid goals.
-
In a ruling that has risk managers and attorneys across the country watching for repercussions, the Supreme Court of Washington state recently ruled that requiring a certificate of merit for a medical malpractice case is unconstitutional.
-
Risk managers who take a good look at their organization's psychiatric treatment may find reason to worry, because the risk mitigation that works in other areas might not be as effective in this field.
-
If your health care organization is self-insured, the government is holding up a new hoop and waiting for you to jump through it.
-
To comply with the reporting requirements of MMSEA Section 111, an affected health care provider must first register with the Centers for Medicare & Medicaid Services (CMS) Coordination of Benefits Contractor (COBC).
-
A pregnant woman presented to a hospital emergency department (ED) for delivery of her third child. Because of her high-risk pregnancy, the woman was scheduled for a cesarean. The cesarean was performed, followed by a hysterectomy. However, complications arose during the hysterectomy, and the woman slipped into a coma and died three days later.
